New hires and promotions in the med-tech industry, including: Exthera, Heartbeam, Owlet, Virocell.
Read More
Brian brings a wealth of relevant experience to the company as it embarks on its next phase of growth, having spent the last four years as CFO of the Cell and Gene Therapy Catapult
CDMO ViroCell Biologics has announced the appointment of Brian Collins as Chief Financial Officer (CFO).
Read More
Brian’s appointment adds to an experienced leadership team that will drive ViroCell’s growth strategy to become a leading global specialist CDMO in cell and gene therapy
London, UK and New York, US, 26 July 2023 – ViroCell Biologics (“ViroCell” or the “Company”), a specialist Contract Development and Manufacturing Organisation (“CDMO”) in cell and gene therapy clinical trials, announces the appointment of Brian Collins as Chief Financial Officer (“CFO”).
Read More